Microcephaly
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Abstracts from the 51st European Society of Human Genetics Conference: Oral Presentations.
|
31270415 |
2019 |
Microcephaly
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Abstracts from the 51st European Society of Human Genetics Conference: Oral Presentations.
|
31270415 |
2019 |
Seizures
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Abstracts from the 51st European Society of Human Genetics Conference: Oral Presentations.
|
31270415 |
2019 |
Seizures
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Abstracts from the 51st European Society of Human Genetics Conference: Oral Presentations.
|
31270415 |
2019 |
Global developmental delay
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Abstracts from the 51st European Society of Human Genetics Conference: Oral Presentations.
|
31270415 |
2019 |
Global developmental delay
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Abstracts from the 51st European Society of Human Genetics Conference: Oral Presentations.
|
31270415 |
2019 |
Abnormal cortical gyration
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Abstracts from the 51st European Society of Human Genetics Conference: Oral Presentations.
|
31270415 |
2019 |
Abnormal cortical gyration
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Abstracts from the 51st European Society of Human Genetics Conference: Oral Presentations.
|
31270415 |
2019 |
Intellectual Disability
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Abstracts from the 51st European Society of Human Genetics Conference: Oral Presentations.
|
31270415 |
2019 |
Intellectual Disability
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Abstracts from the 51st European Society of Human Genetics Conference: Oral Presentations.
|
31270415 |
2019 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.
|
29483656 |
2018 |
mathematical ability
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |
Child Development Disorders, Pervasive
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
|
28540026 |
2017 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
|
28540026 |
2017 |
Tumor Cell Invasion
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
The present study was designed to further characterize TMX2-28 cells and elucidate their invasion mechanism.
|
23255405 |
2013 |
Tumor Cell Invasion
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
In the present study, PRL-activated PAK1 stimulates the invasion of TMX2-28 human breast cancer cells through Matrigel.
|
23744893 |
2013 |
Congenital microcephaly
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We describe a severe neurological disorder caused by bi-allelic loss-of-function variants in thioredoxin (TRX)-related transmembrane-2 (TMX2); these variants were detected by exome sequencing in 14 affected individuals from ten unrelated families presenting with congenital microcephaly, cortical polymicrogyria, and other migration disorders.
|
31735293 |
2019 |
Malignant neoplasm of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
Use of the triple-negative TMX2-28 breast cancer cell line to address the role of SKP2 in cell cycle progression confirmed that SKP2 contributes to a more rapid cell cycle progression and may regulates pSer10p27 levels.
|
24443386 |
2014 |
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Use of the triple-negative TMX2-28 breast cancer cell line to address the role of SKP2 in cell cycle progression confirmed that SKP2 contributes to a more rapid cell cycle progression and may regulates pSer10p27 levels.
|
24443386 |
2014 |